We radically improve the probability of success in drug development by getting right what really matters: human evidence to back the target and prognostic disease signatures to define the population.
cbs
5 followers
Fortrea
23 followers
Merck Group
91 followers
EUROIMMUN
2 followers
SMS Group
4 followers
Vantive
12 followers
Isomorphic Labs
18 followers
Eugia Pharma Specialities Ltd
2 followers
Advanced Clinical
2 followers
AIXIAL GROUP
2 followers
Uniklinik RWTH Aachen
1 follower
The START Center for Cancer Research
3 followers